Education
About Us
Working with TipRanks
Follow Us
Denali Therapeutics (DE:4DN)
FRANKFURT:4DN
4DN Analyst Ratings
Strong Buy
11 Buy
1 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
4DN Stock 12 Month Forecast
Average Price Target
€28.95
▲(59.48% Upside)
| Highest Price Target€34.62 | Average Price Target€28.95 | Lowest Price Target€21.64 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Bank of America Securities
€25.1
Buy
38.31%
Upside
Reiterated
03/03/26
H.C. Wainwright
€27.7
Buy
52.61%
Upside
Reiterated
03/02/26
Oppenheimer
€30.3
Buy
66.92%
Upside
Reiterated
03/02/26
BTIG
€27.7→€31.16
Buy
71.69%
Upside
Reiterated
03/02/26
William Blair
―
Buy
―
Reiterated
02/27/26
Stifel Nicolaus
€32.03→€29.43
Buy
62.15%
Upside
Reiterated
02/27/26
TD Cowen
―
Buy
―
Reiterated
02/26/26
Wolfe Research
―
Hold
―
Initiated
02/23/26
Morgan Stanley
€34.62
Buy
90.77%
Upside
Reiterated
02/10/26
Wedbush
€25.97
Buy
43.07%
Upside
Reiterated
02/06/26
UBS
€21.64
Buy
19.23%
Upside
Initiated
01/06/26
B. Riley Securities
€25.97
Buy
43.07%
Upside
Reiterated
12/01/25
J.P. Morgan
€22.51
Buy
24.00%
Upside
Reiterated
11/03/25
Cantor Fitzgerald
―
Buy
―
Reiterated
09/08/25
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Bank of America Securities
€25.1
Buy
38.31%
Upside
Reiterated
03/03/26
H.C. Wainwright
€27.7
Buy
52.61%
Upside
Reiterated
03/02/26
Oppenheimer
€30.3
Buy
66.92%
Upside
Reiterated
03/02/26
BTIG
€27.7→€31.16
Buy
71.69%
Upside
Reiterated
03/02/26
William Blair
―
Buy
―
Reiterated
02/27/26
Stifel Nicolaus
€32.03→€29.43
Buy
62.15%
Upside
Reiterated
02/27/26
TD Cowen
―
Buy
―
Reiterated
02/26/26
Wolfe Research
―
Hold
―
Initiated
02/23/26
Morgan Stanley
€34.62
Buy
90.77%
Upside
Reiterated
02/10/26
Wedbush
€25.97
Buy
43.07%
Upside
Reiterated
02/06/26
UBS
€21.64
Buy
19.23%
Upside
Initiated
01/06/26
B. Riley Securities
€25.97
Buy
43.07%
Upside
Reiterated
12/01/25
J.P. Morgan
€22.51
Buy
24.00%
Upside
Reiterated
11/03/25
Cantor Fitzgerald
―
Buy
―
Reiterated
09/08/25
Best Analysts Covering Denali Therapeutics
3 Months
xxx
Success Rate
10/16 ratings generated profit
Average Return
+3.14%
a xxx
rating ―
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 62.50% of your transactions generating a profit, with an average return of +3.14% per trade.
1 Year
Success Rate
9/13 ratings generated profit
Average Return
+7.31%
a rating ―
Copying Tazeen Ahmad's trades and holding each position for 1 Year would result in 69.23% of your transactions generating a profit, with an average return of +7.31% per trade.
2 Years
xxx
Success Rate
10/13 ratings generated profit
Average Return
+11.02%
a xxx
rating ―
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 76.92% of your transactions generating a profit, with an average return of +11.02% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
4DN Analyst Recommendation Trends
Rating
Nov 25
Dec 25
Jan 26
Feb 26
Mar 26
Strong Buy
13
18
16
17
14
Buy
6
7
8
10
9
Hold
0
0
0
1
1
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
19
25
24
28
24
Each month's total comprises the sum of three months' worth of ratings.
4DN Financial Forecast
4DN Stock Forecast FAQ
What is DE:4DN’s average 12-month price target, according to analysts?
Based on analyst ratings, Denali Therapeutics’s 12-month average price target is 28.95.
What is DE:4DN’s upside potential, based on the analysts’ average price target?
Denali Therapeutics has 59.48% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Denali Therapeutics a Buy, Sell or Hold?
Denali Therapeutics has a consensus rating of Strong Buy, which is based on 11 buy ratings, 1 hold ratings and 0 sell ratings.
What is Denali Therapeutics’s share price target?
The average share price target for Denali Therapeutics is 28.95. This is based on 12 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €34.62 ,and the lowest forecast is €21.64. The average share price target represents 59.48% Increase from the current price of €18.15.
The highest analyst share price target is €34.62 ,and the lowest forecast is €21.64. The average share price target represents 59.48% Increase from the current price of €18.15.
What do analysts say about Denali Therapeutics?
Denali Therapeutics’s analyst rating consensus is a Strong Buy. This is based on the ratings of 12 Wall Streets Analysts.
How can I buy shares of Denali Therapeutics?
To buy shares of DE:4DN, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.